Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS

Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS

Biomarkers research in amyotrophic lateral sclerosis (ALS) holds the promise of improving ALS diagnosis, follow-up of patients, and clinical trials outcomes. Metabolomics have a big impact on biomarkers identification. In this mini-review, we provide the main findings of metabolomics studies in ALS...

Full description

Bibliographic Details
Main Authors: Débora Lanznaster, Denis Reis de Assis, Philippe Corcia, Pierre-François Pradat, Hélène Blasco
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-12-01
Series:Frontiers in Neurology
Subjects:
ALS
metabolomics
pharmacometabolomics
therapeutic
creatinine
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2018.01126/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2018.01126/full

Similar Items